• 位置 Location

  分别位于烟台开发区八角街道白银河以北区域、高新区核心区南部、牟平区沁水韩国工业园内。

  The industry cluster is distributed in the north of the Baiyin River in Bajiao Subdistrict, Yantai Economic and Technological Development Area, the south of the core area of Yantai Hi-tech Industrial Development Zone, and in the Qinshui South Korea Industrial Park in Muping District.

• ​发展方向 Development Direction

  依托国家综合性新药研究开发技术大平台烟台基地等国家级创新平台及一批龙头企业，以海洋生物与医药科技研发为特色，以生物药和高端医疗器械为核心，打造世界级生物医药产业集聚区、国际生物药谷。

  Relying on the Yantai Base of the National Comprehensive Platform for Drug Discovery and Development and other national-level innovation platforms as well as a number of leading enterprises, efforts will be made to build a world-class biopharmaceutical industry cluster and an international biopharmaceutical base. Both the industry cluster and base will focus on the research and development of marine biological and pharmaceutical technologies, and will be centered on biopharmaceuticals and high-end medical devices.

• 发展目标 Development Goal

  到2025年，落地世界500强及行业领军企业项目14个，产业规模达到800亿元。

  By 2025, 14 projects from Fortune Global 500 enterprises and industry-leading enterprises will have been implemented, with an industrial output up to RMB 80 billion.

• 产业基础 Industrial Base

  集聚区内拥有“国家火炬计划海洋生物与医药特色产业基地”等多个国字号招牌，培育了一大批行业龙头企业和细分领域骨干企业，拥有国家综合性新药研发技术大平台示范企业3个、国家级省级企业技术中心20个，产品涵盖生物制药、医疗器械、诊断试剂与疫苗、现代中药、生物保健品等多个领域。

  The industry cluster is currently home to a number of national brands, including the Special Industry Base of Marine Biology and Pharmaceuticals under the National Torch Plan. It also encompasses a significant number of industry-leading enterprises and backbone enterprises in various segments, as well as three demonstration enterprises under the National Comprehensive Platform for Drug Discovery and Development, and 20 enterprise technology centers at the national and provincial levels. Products in the industry cluster cover a wide range of areas, including biopharmaceuticals, medical devices, diagnostic reagents and vaccines, modern traditional Chinese medicine, and biological health products.

• 招商方向 Direction of Investment Attraction

  培育壮大生物医药、医疗器械、海洋健康产品等优势产业，以及高技术医药研发和产业化服务外包。

  Focus will be on cultivating and expanding competitive industries such as biopharmaceuticals, medical devices and marine health products, as well as on high-tech pharmaceutical R&D and industrialization service outsourcing.

说明：以上数据来源于第三方网络，仅做投资参考！
Explanation: The above data is sourced from third-party networks and is for investment reference only!